Free Access
Med Sci (Paris)
Volume 24, Number 8-9, Août-Septembre 2008
Page(s) 742 - 746
Section M/S revues
Published online 15 August 2008
  1. De Ruijter AJ, van Gennip AH, Caron HN, et al. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003; 370 : 737–49. [Google Scholar]
  2. Marks PA, Miller T, Richon VM. Histone deacetylases. Curr Opin Pharmacol 2003; 3 : 344–51. [Google Scholar]
  3. Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deacetylase inhibitors. Nat Rev Drug Discov 2006; 5 : 769–84. [Google Scholar]
  4. Dokmanovic M, Clarke C, Marks PA. Histone deacetylase inhibitors: overview and perspectives. Mol Cancer Res 2007; 5 : 981–9. [Google Scholar]
  5. Marks PA, Richon VM, Breslow R, Rifkind RA. Histone deacetylase inhibitors as new cancer drugs. Curr Opin Oncol 2001; 13 : 477–83. [Google Scholar]
  6. Dokmanovic M, Marks PA. Prospects: histone deacetylase inhibitors. J Cell Biochem 2005; 96 : 293–304. [Google Scholar]
  7. Johnstone RW. Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat Rev Drug Discov 2002; 1 : 287–99. [Google Scholar]
  8. Piekarz RL, Sackett DL, Bates SE. Histone deacetylase inhibitors and demethylating agents: clinical development of histone deacetylase inhibitors for cancer therapy. Cancer J 2007; 13 : 30–9. [Google Scholar]
  9. Rasheed WK, Johnstone RW, Prince HM. Histone deacetylase inhibitors in cancer therapy. Expert Opin Investig Drugs 2007; 16 : 659–78. [Google Scholar]
  10. Xu WS, Parmigiani RB, Marks PA. Histone deacetylase inhibitors: molecular mechanisms of action. Oncogene 2007; 26 : 5541–52. [Google Scholar]
  11. Glozak MA, Sengupta N, Zhang X, Seto E. Acetylation and deacetylation of non-histone proteins. Gene 2005; 363 : 15–23. [Google Scholar]
  12. Magnaghi-Jaulin L, Eot-Houllier G, Fulcrand G, Jaulin C. Histone deacetylase inhibitors induce premature sister chromatid separation and override the mitotic spindle assembly checkpoint. Cancer Res 2007; 67 : 6360–7. [Google Scholar]
  13. Qiu JW. Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors. Proc Natl Acad Sci USA 2005; 102 : 673–8. [Google Scholar]
  14. Ungerstedt JS, Sowa Y, Xu WS, et al. Role of thioredoxin in the response of normal and transformed cells to histone deacetylase inhibitors. Proc Natl Acad Sci USA 2005; 102 : 673–8. [Google Scholar]
  15. Saunders LR, Verdin E. Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 2007; 26 : 5489–504. [Google Scholar]
  16. Weber M. Profils de méthylation de l’ADN dans les cellules normales et cancéreuses. Med Sci (Paris) 2008; 24 : 731–4. [Google Scholar]
  17. Bertin A, Mangenot S. Structure et dynamique de la particule cœur de nucléosome. Med Sci (Paris) 2008; 24 : 715–9. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.